| Epoprostenol | hsa00140 | Steroid hormone biosynthesis | 4.52E-02 | 1 | P22680 | CYP7A1 | More | |
| Epoprostenol | hsa03020 | RNA polymerase | 3.98E-05 | 2 | Q9GZM3, P52435 | POLR2J2, POLR2J | More | |
| Epoprostenol | hsa03320 | PPAR signaling pathway | 2.18E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | |
| Epoprostenol | hsa04114 | Oocyte meiosis | 9.38E-03 | 4 | P51812, Q02750, P16298, Q17RY0 | RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | |
| Epoprostenol | hsa04145 | Phagosome | 3.99E-02 | 4 | P05164, P78380, P35443, P13765 | MPO, OLR1, THBS4, HLA-DOB | More | |
| Epoprostenol | hsa04370 | VEGF signaling pathway | 1.04E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | |
| Epoprostenol | hsa04612 | Antigen processing and presentation | 1.31E-03 | 6 | P13765, P26715, P26717, Q07444, Q13241, P01732 | HLA-DOB, KLRC1, KLRC2, KLRC3, KLRD1, CD8A | More | |
| Epoprostenol | hsa04640 | Hematopoietic cell lineage | 4.90E-03 | 6 | P25063, P07766, P01732, P09564, P13765, P09603 | CD24, CD3E, CD8A, CD7, HLA-DOB, CSF1 | More | |
| Epoprostenol | hsa04650 | Natural killer cell mediated cytotoxicity | 2.63E-07 | 12 | P16298, P50591, P06239, O60880, P20963, Q02750, Q13241, P26718, O14931, P26717, Q07444, P26715 | PPP3CB, TNFSF10, LCK, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, NCR3, KLRC2, KLRC3, KLRC1 | More | |
| Epoprostenol | hsa04658 | Th1 and Th2 cell differentiation | 5.90E-06 | 8 | Q04759, P07766, P20963, P06239, Q14765, Q9UL17, P13765, Q13761 | PRKCQ, CD3E, CD247, LCK, STAT4, TBX21, HLA-DOB, RUNX3 | More | |
| Epoprostenol | hsa04659 | Th17 cell differentiation | 3.38E-04 | 7 | Q04759, P06239, P13765, Q9HBE5, Q9UL17, P07766, P20963 | PRKCQ, LCK, HLA-DOB, IL21R, TBX21, CD3E, CD247 | More | |
| Epoprostenol | hsa04660 | T cell receptor signaling pathway | 8.49E-04 | 7 | Q04759, Q08881, P07766, P20963, P01732, Q13191, P06239 | PRKCQ, ITK, CD3E, CD247, CD8A, CBLB, LCK | More | |
| Epoprostenol | hsa04662 | B cell receptor signaling pathway | 3.17E-02 | 2 | P16298, Q02750 | PPP3CB, MAP2K1 | More | |
| Epoprostenol | hsa04720 | Long-term potentiation | 1.05E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | |
| Epoprostenol | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.74E-02 | 3 | P22694, P24723, Q04759 | PRKACB, PRKCH, PRKCQ | More | |
| Epoprostenol | hsa04913 | Ovarian steroidogenesis | 2.72E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | |
| Epoprostenol | hsa04914 | Progesterone-mediated oocyte maturation | 2.27E-02 | 3 | Q17RY0, P51812, Q02750 | CPEB4, RPS6KA3, MAP2K1 | More | |
| Epoprostenol | hsa04974 | Protein digestion and absorption | 4.52E-02 | 1 | Q03692 | COL10A1 | More | |
| Epoprostenol | hsa04975 | Fat digestion and absorption | 4.98E-02 | 1 | Q6PCB7 | SLC27A1 | More | |
| Epoprostenol | hsa05016 | Huntington disease | 3.63E-03 | 3 | Q9GZM3, P52435, O60282 | POLR2J2, POLR2J, KIF5C | More | |
| Epoprostenol | hsa05100 | Bacterial invasion of epithelial cells | 1.05E-02 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | |
| Epoprostenol | hsa05135 | Yersinia infection | 9.38E-03 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | |
| Epoprostenol | hsa05146 | Amoebiasis | 6.67E-04 | 6 | P09341, P19875, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, ARG1, PRKACB, ACTN1, CTSG | More | |
| Epoprostenol | hsa05170 | Human immunodeficiency virus 1 infection | 1.65E-02 | 4 | Q02750, P62879, P16298, Q05397 | MAP2K1, GNB2, PPP3CB, PTK2 | More | |
| Epoprostenol | hsa05222 | Small cell lung cancer | 4.91E-02 | 2 | Q13751, P98170 | LAMB3, BIRC4 | More | |
| Epoprostenol | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.73E-02 | 4 | P07766, P20963, P06239, Q04759 | CD3E, CD247, LCK, PRKCQ | More | |
| Epoprostenol | hsa05310 | Asthma | 2.72E-02 | 2 | P13765, P12724 | HLA-DOB, RNASE3 | More | |
| Epoprostenol | hsa05321 | Inflammatory bowel disease | 2.22E-03 | 4 | P13765, Q14765, Q9UL17, Q9HBE5 | HLA-DOB, STAT4, TBX21, IL21R | More | |
| Epoprostenol | hsa05323 | Rheumatoid arthritis | 3.51E-03 | 4 | P09603, P13765, P09341, P19875 | CSF1, HLA-DOB, CXCL1, CXCL2 | More | |
| Epoprostenol | hsa05332 | Graft-versus-host disease | 9.74E-03 | 3 | P13765, P26715, Q13241 | HLA-DOB, KLRC1, KLRD1 | More | |
| Epoprostenol | hsa05340 | Primary immunodeficiency | 2.86E-02 | 3 | P01732, P07766, P06239 | CD8A, CD3E, LCK | More | |
